1. 2018
  2. Personalised Follow-up of QOL in longitudinal studies: the example of promising experimental treatment of recurrent glioblastoma with avelumab and axitinib

    Rogiers, A. I., Theuns, P., De Cremer, J., Bernheim, J. & Neyns, B., 13 Jun 2018, Personalised Follow-up of QOL in longitudinal studies: the example of promising experimental treatment of recurrent glioblastoma with avelumab and axitinib.

    Research output: Chapter in Book/Report/Conference proceedingMeeting abstract (Book)Research

  3. Inhibition of system xc-: tackling pancreatic cancer from different angles

    Lara, O., Rooman, I. & Massie, A., 8 Jun 2018, (Unpublished).

    Research output: Unpublished contribution to conferencePosterResearch

  4. Cancer immunotherapy-associated hypophysitis

    Solinas, C., Porcu, M., De Silva, P., Musi, M., Aspeslagh, S., Scartozzi, M., Willard-Gallo, K., Mariotti, S. & Saba, L., Jun 2018, In : Seminars in oncology. 45, 3, p. 181-186 6 p.

    Research output: Contribution to journalScientific reviewResearchpeer-review

  5. The CoCoS trial: Caloric Control in Cardiac Surgery patients promotes survival, an interventional trial with retrospective control

    De Waele, E., Nguyen, D. N., De Bondt, K., La Meir, M., Diltoer, M., Honoré, P., Spapen, H. & Pen, J., Jun 2018, In : Clinical Nutrition. 37, 3, p. 864-869 6 p.

    Research output: Contribution to journalArticleResearchpeer-review

  6. Phase I results of CAM-H2: Safety profile and tumor targeting in patients.

    Keyaerts, M., De Vos, J., Duhoux, F. P., Caveliers, V., Fontaine, C. & Vanhoeij, M., 20 May 2018, In : Journal of Clinical Oncology. 36, 15, p. e13017-e13017 1 p.

    Research output: Contribution to journalMeeting abstract (Journal)Research

  7. The Relationship between a New Biomarker of Vagal Neuroimmunomodulation and Survival in Two Fatal Cancers.

    Gidron, Y., De Couck, M., Schallier, D., De Grève, J., Van Laethem, J-L. & Maréchal, R., 8 May 2018, In : J Immunol Res. 2018, p. 4874193 5 p., 4874193.

    Research output: Contribution to journalArticleResearchpeer-review

  8. The relationship between a new biomarker of vagal neuroimmunomodulation and survival in two fatal cancers

    Gidron, Y., De Couck, M., Schallier, D., De Grève, J., Van Laethem, J-L. & Maréchal, R., 8 May 2018, Journal of Immunology Research, 5 p. (J Immunol Res; vol. 2018, no. 4874193).

    Research output: Working paperResearch

  9. Insights on melatonin as an active pharmacological molecule in cancer prevention: what's new?

    Bjorklund, G., Rajib, S. A., Saffoon, N., Pen, J. J. & Chirumbolo, S., 1 May 2018, In : Current Medicinal Chemistry. 25

    Research output: Contribution to journalArticleResearchpeer-review

  10. Immunotherapy phase I trials in patients Older than 70 years with advanced solid tumours

    Herin, H., Aspeslagh, S., Castanon, E., Dyevre, V., Marabelle, A., Varga, A., Postel Vinay, S., Michot, J. M., Ribrag, V., Gazzah, A., Bahleda, R., Mir, O., Massard, C., Hollebecque, A., Soria, J. C. & Baldini, C., May 2018, In : European Journal of Cancer. 95, p. 68-74 7 p.

    Research output: Contribution to journalArticleResearchpeer-review

Previous 1...3 4 5 6 7 8 9 10 ...51 Next

ID: 25692